Hera-MI
Analysis completed on 3/20/2026
While Hera-MI addresses a critical, high-utility problem in medical imaging and breast cancer detection, the provided submission contains highly exaggerated and contradictory claims. Stating that 'most people have used my product' for a B2B AI medical device, listing the audience as 'everyone,' and reporting an 'all time marketcap' of 50,000 against a 125-person team size significantly damages the credibility of the application. The low response quality and lack of verifiable traction metrics result in a heavily penalized score.
Ready to Compete for $150k+ in Prizes?
Move this data into a HackerNoon blog draft to become eligible for your share of $150k+ in cash and software prizes
Score Breakdown
Project Details
Algorithm Insights
Recommendations to Increase Usefulness Score
Document User Growth
Provide specific metrics on user acquisition and retention rates
Showcase Revenue Model
Detail sustainable monetization strategy and current revenue streams
Expand Evidence Base
Include testimonials, case studies, and third-party validation
Technical Roadmap
Share development milestones and feature completion timeline